OA-225 Optimising second line anchor drug options for children with HIV in Africa: 96 week results of the CHAPAS-4 randomised trial by Lugemwa, Abbas, Szubert, Alexander J, Ndebele, Wedu, Walker, Sarah, Turkova, Anna, Tafeni, Sue, Siziba, Grace, Shakeshaft, Clare, Nduna, Bwendo, Nazzinda, Rashida, Nambi, Esether, Mwamabazi, Mwate, Musoro, Godfrey, Musiime, Victor, Mulenga, Veronica, Mujuru, Hilda, McIlleron, Helen, Makumbi, Shafic, Lungu, Joyce, Kityo, Cissy, Dudakia, Nimisha, Doerholt, Katja, Chabala, Chishala, Bwakura-Dangarembizi, Mutsa, Bamford, Alasdair, Gibb, Diana M

Request full text